Recent News

• 05.12.2026 - Lexicon Pharmaceuticals to Present at the 4th Annual H.C. Wainwright BioConnect Investor Conference
• 05.07.2026 - Lexicon Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Clinical Updates
• 05.04.2026 - Lexicon Pharmaceuticals Announces $100 Million Loan Facility with Hercules Capital
• 04.30.2026 - Lexicon Pharmaceuticals to Report First Quarter 2026 Financial Results on May 7, 2026
• 04.17.2026 - Lexicon to Present Data at the American Academy of Neurology (AAN) Annual Meeting

Recent Filings

• 05.08.2026 - 4 Statement of changes in beneficial ownership of securities
• 05.08.2026 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
• 05.07.2026 - 8-K Current report
• 05.07.2026 - EX-99.1 EX-99.1
• 05.07.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 05.06.2026 - 8-K Current report
• 05.06.2026 - EX-99.1 EX-99.1
• 05.04.2026 - 4 Statement of changes in beneficial ownership of securities
• 05.04.2026 - 4 Statement of changes in beneficial ownership of securities
• 05.04.2026 - 4 Statement of changes in beneficial ownership of securities